Related references
Note: Only part of the references are listed.First-Year Visual Acuity Outcomes of Providing Aflibercept According to the VIEW Study Protocol for Age-Related Macular Degeneration
James S. Talks et al.
OPHTHALMOLOGY (2016)
GENETIC FACTORS ASSOCIATED WITH CHOROIDAL VASCULAR HYPERPERMEABILITY AND SUBFOVEAL CHOROIDAL THICKNESS IN POLYPOIDAL CHOROIDAL VASCULOPATHY
Seigo Yoneyama et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2016)
Prevalence and Genetic Characteristics of Geographic Atrophy among Elderly Japanese with Age-Related Macular Degeneration
Yoichi Sakurada et al.
PLOS ONE (2016)
One-Year Result of Aflibercept Treatment on Age-Related Macular Degeneration and Predictive Factors for Visual Outcome
Akio Oishi et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2015)
MMP20 and ARMS2/HTRA1 Are Associated with Neovascular Lesion Size in Age-Related Macular Degeneration
Yumiko Akagi-Kurashige et al.
OPHTHALMOLOGY (2015)
Factors Associated with Recurrence of Age-Related Macular Degeneration after Anti-Vascular Endothelial Growth Factor Treatment
Yoshimasa Kuroda et al.
OPHTHALMOLOGY (2015)
Prospective Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration TREX-AMD 1-Year Results
Charles C. Wykoff et al.
OPHTHALMOLOGY (2015)
One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy
Akiko Yamamoto et al.
OPHTHALMOLOGY (2015)
ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION A Treat-and-Extend Protocol Over 2 Years
Farshad Abedi et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2014)
Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration
Brandon G. Busbee et al.
OPHTHALMOLOGY (2013)
Genetic Influences on the Outcome of Anti-Vascular Endothelial Growth Factor Treatment in Neovascular Age-related Macular Degeneration
Farshad Abedi et al.
OPHTHALMOLOGY (2013)
Pharmacogenetics for Genes Associated with Age-related Macular Degeneration in the Comparison of AMD Treatments Trials (CATT)
Stephanie A. Hagstrom et al.
OPHTHALMOLOGY (2013)
Factors Associated With the Response of Age-Related Macular Degeneration to Intravitreal Ranibizumab Treatment
Kenji Yamashiro et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2012)
Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
Usha Chakravarthy et al.
OPHTHALMOLOGY (2012)
Association of genetic polymorphisms with response to bevacizumab for neovascular age-related macular degeneration in the Chinese population
Jun Tian et al.
PHARMACOGENOMICS (2012)
ASSOCIATION BETWEEN HIGH-RISK DISEASE LOCI AND RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR WET AGE-RELATED MACULAR DEGENERATION
Anton Orlin et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2012)
Choroidal Thickness, Vascular Hyperpermeability, and Complement Factor H in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
Pichai Jirarattanasopa et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Complement factor H Y402H gene polymorphism and response to intravitreal bevacizumab in exudative age-related macular degeneration
Christian Nischler et al.
ACTA OPHTHALMOLOGICA (2011)
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group
Daniel F. Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Complement Factor H and High-Temperature Requirement A-1 Genotypes and Treatment Response of Age-related Macular Degeneration
Takashi Tsuchihashi et al.
OPHTHALMOLOGY (2011)
The Prevalence of Age-Related Macular Degeneration in Asians A Systematic Review and Meta-Analysis
Ryo Kawasaki et al.
OPHTHALMOLOGY (2010)
ASSOCIATION OF LOC387715 A69S GENOTYPE WITH VISUAL PROGNOSIS AFTER PHOTODYNAMIC THERAPY FOR POLYPOIDAL CHOROIDAL VASCULOPATHY
Yoichi Sakurada et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
ANGIOGRAPHIC LESION SIZE ASSOCIATED WITH LOC387715 A69S GENOTYPE IN SUBFOVEAL POLYPOIDAL CHOROIDAL VASCULOPATHY
Yoichi Sakurada et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)
Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 1
Carl D. Regillo et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Clinical phenotypes associated with the complement factor h Y402H variant in age-related macular degeneration
Milam A. Brantley et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
David M. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Share Paper
